Biotech · Private company
Sucampo Pharma Americas, LLC
Track this companyFree. Adds Sucampo Pharma Americas, LLC to your Dealase workspace and tells you when its record changes.
Clinical trials150 recruiting or active
Pipeline programs16From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline16
- Cohort 1: Lubiprostone Capsule, FastedPhase 3 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- Cohort 1: Lubiprostone Sprinkle Formulation, FastedPhase 3 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- Cohort 2: Lubiprostone Sprinkle Formulation, FastedPhase 3 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- Cohort 2: Lubiprostone Sprinkle Formulation, FedPhase 3 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- LubiprostonePhase 3 · Chronic Idiopathic ConstipationClinicalTrials.gov · fetched Nov 12, 2026
- LubiprostonePhase 3 · Opioid-induced Bowel DysfunctionClinicalTrials.gov · fetched Nov 12, 2026
- LubiprostonePhase 3 · Constipation - FunctionalClinicalTrials.gov · fetched Nov 12, 2026
- Lubiprostone 24Phase 3 · Opioid-Induced Bowel DysfunctionClinicalTrials.gov · fetched Nov 12, 2026
- CobiprostonePhase 2 · NSAID-induced Gastroduodenal InjuryClinicalTrials.gov · fetched Nov 12, 2026
- CobiprostonePhase 2 · Oral MucositisClinicalTrials.gov · fetched Nov 12, 2026
- CobiprostonePhase 2 · Portal HypertensionClinicalTrials.gov · fetched Nov 12, 2026
- LubiprostonePhase 2 · Irritable Bowel SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- Non-steroidal anti-inflammatory drugPhase 2 · NSAID-induced Gastroduodenal InjuryClinicalTrials.gov · fetched Nov 12, 2026
- Standard Care - ChemotherapyPhase 2 · Oral MucositisClinicalTrials.gov · fetched Nov 12, 2026
- Standard Care - RadiationPhase 2 · Oral MucositisClinicalTrials.gov · fetched Nov 12, 2026
- LubiprostoneConstipationClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials15
- Evaluation of the Bioequivalence of Sprinkle and Capsule Formulations of Lubiprostone, as Compared to PlaceboPHASE3 · COMPLETED · started Mar 13, 2017ClinicalTrials.gov NCT03097861 · fetched Nov 12, 2026
- Comparative Pharmacokinetics and Food-Effect Bioavailability of Lubiprostone Sprinkle in Healthy VolunteersPHASE3 · COMPLETED · started Nov 16, 2016ClinicalTrials.gov NCT03010631 · fetched Nov 12, 2026
- Evaluation of the Safety of Lubiprostone in Pediatric Participants Aged ≥ 6 Years to < 18 Years With Functional ConstipationPHASE3 · COMPLETED · started Apr 12, 2016ClinicalTrials.gov NCT02766777 · fetched Nov 12, 2026
- Cobiprostone for the Prevention of Oral Mucositis in Subjects With Head and Neck Cancer Receiving Concurrent Radiation and ChemotherapyPHASE2 · TERMINATED · started Jun 1, 2015ClinicalTrials.gov NCT02542215 · fetched Nov 12, 2026
- Evaluation of the Efficacy and Safety of Lubiprostone in Adults With Mixed or Unsubtyped Irritable Bowel SyndromePHASE2 · TERMINATED · started Feb 1, 2015ClinicalTrials.gov NCT02544152 · fetched Nov 12, 2026
- Lubiprostone for Children With ConstipationPHASE3 · COMPLETED · started Feb 26, 2014ClinicalTrials.gov NCT02138136 · fetched Nov 12, 2026
- Lubiprostone in Children With Functional ConstipationPHASE3 · COMPLETED · started Dec 13, 2013ClinicalTrials.gov NCT02042183 · fetched Nov 12, 2026
- Pharmacodynamic, Pharmacokinetic, and Tolerability Study of a Liquid Form of Lubiprostone in Adult Subjects With Chronic Idiopathic ConstipationPHASE3 · COMPLETED · started Oct 1, 2013ClinicalTrials.gov NCT01993875 · fetched Nov 12, 2026
- Opioid-induced Bowel Dysfunction (OBD) Pivotal Assessment of Lubiprostone (OPAL)PHASE3 · COMPLETED · started Dec 1, 2010ClinicalTrials.gov NCT01298219 · fetched Nov 12, 2026
- Efficacy and Safety of Cobiprostone in Patients With Portal HypertensionPHASE2 · TERMINATED · started Jul 1, 2008ClinicalTrials.gov NCT00737594 · fetched Nov 12, 2026
- Opioid-induced Bowel Dysfunction: Long-Term Assessment of LubiprostonePHASE3 · COMPLETED · started Dec 1, 2007ClinicalTrials.gov NCT00620061 · fetched Nov 12, 2026
- Opioid-induced Bowel Dysfunction: Pivotal Assessment of LubiprostonePHASE3 · COMPLETED · started Aug 1, 2007ClinicalTrials.gov NCT00595946 · fetched Nov 12, 2026
- Opioid-induced Bowel Dysfunction Pivotal Assessment of LubiprostonePHASE3 · COMPLETED · started Aug 1, 2007ClinicalTrials.gov NCT00597428 · fetched Nov 12, 2026
- Cobiprostone Prevention of NSAID-induced Gastroduodenal InjuryPHASE2 · COMPLETED · started Aug 1, 2007ClinicalTrials.gov NCT00597818 · fetched Nov 12, 2026
- Safety and Efficacy of Lubiprostone in Pediatric Patients With ConstipationPHASE4 · COMPLETED · started Jan 1, 2007ClinicalTrials.gov NCT00452335 · fetched Nov 12, 2026